Aim To analyse clinical, laboratory and epidemiological characteristics of brucellosis in children in Bosnia and Herzegovina. Methods The study included 246 children aged 0-18 years, who were hospitalized in Clinics and Departments for Infectious Diseases in Tuzla, Sarajevo, Banja Luka, Zenica and Bihać in the period 2000-2013, in whom the diagnosis of brucellosis was established based on anamnestic data, clinical features and positive results from blood culture and/or positive results from one of the serological tests. Results In this period, a total of 2630 patients, 246 (9.35%) of whom were children, were treated from brucellosis at the Clinics and Departments in Bosnia and Herzegovina. In the majority of cases, the children were from rural parts of the country, 226 (91.87%);214 (87.04%) cases had direct contact with sick animals, sick family member or consumption of unpasteurized dairy products from farms where brucellosis had been already established. Male children predominated, 157 (63.82%). The most frequent clinical features in affected children were fever, 194 (78.86%) and joint pain, 158 (64.22%). The average duration of antimicrobial treatment was 42.85 ± 10.67 days. A total of 228 (92.68%) children were completely cured, while relapses occurred in 18 (7.32%) children. Conclusion Since brucellosis is an endemic disease in Bosnia and Herzegovina, it is important that physicians in their daily practice consider brucellosis and establish proper diagnosis and therapy in children with prolonged fever, arthralgia, leukopenia and positive epidemiological data, especially in rural parts of the country.
Jeren T, Begovac J, Božinović D, Lisić M, Baršić B, Schönwald S. Brucella species. Infektologija 1st Ed Zagreb: Profil. 2006;629–31.
2.
Young E. In: Long SS, Pickering LK, Prober CG. Principles and practice of Pediatric Infectious Diseases. 2008;855–8.
3.
Abdussalam M, Fein D. Brucellosis as a world problem. Dev Biol Stand. 1976;9–23.
4.
Corbel M. Brucellosis in humans and animals. 2006;1–86.
5.
Pappas G, Akritidis N, Bosilovski M, Brucellosis T. N Engl J Med. 2005;2325–36.
6.
Giannakopoulos I, Nikolakopoulou N, Eliopoulou M, Ellina A, Kolonitsiou F, Papanastasiou D. Presentation of childhood Brucellosis in Western Greece. Jpn J Infect Dis. 2006;160–3.
7.
Bosilovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis. 2007;342–7.
8.
Dequi S, Donglou X, Jiming Y. Epidemiology and control of brucellosis in China. Vet Microbiol. 2002;165–82.
9.
Okur M, Erbey F, Bektaş M, Kaya A, Doğan M, Acar M, et al. Retrospectiveclinical and laboratory evaluation of children with brucellosis. Pedia-trInt. 2012;215–8.
10.
Sharda D, Lubani M. A study of brucellosis in childhood. ClinPediatr. 1986;492–5.
11.
Feiz J, Sabbaghian H, Mirali M. Brucellosis due to B. melitensis in children. ClinPediatr. 1978;904–7.
12.
Mantur B, Akki A, Mangalgi S, Patil S, Gobbur R, Peerapur B. Childhood brucellosis: a microbiological, epidemiological and clinical study. J Trop Pediatr. 2004;153–7.
13.
Street L, Grant W, Alva J. Brucellosis in childhood. Pediatrics. 1975;416–21.
14.
Tsolia M, Drakonaki S, Messaritaki A, Farmakakis T, Kostaki M, Tsapra H, et al. Clinical features, complications and treatment outcome of childhoodbrucellosis in central Greece. J Infect. 2002;257–62.
15.
Obradović Z, Velić R. Epidemiological characteristics of brucellosis inFederation of Bosnia and Herzegovina. Croat Med J. 2010;345–50.
16.
Ahmetagić S, Piljić D, Smriko-Nuhanović A, Ahmetagić A, Topalović B. Kliničke i epidemiološke karakteristike bruceloze u hospitaliziranih bolesnika. Infektol Glas. 2008;135–43.
17.
Tandir S, Sivić S, Toromanović S, Aličajić F. Epidemiology Features of Brucellosis at the Zenica-Doboj Canton Area in Period 2000-2007. Med Arh. 2008;111–3.
18.
Dautović K, S, Čengić H, Mehanić M, Ahmetagić S, Ibrahimpašić S, et al. Brucellosis-emerging zoonosis in Bosnia and Herzegovina. Int J Infect Dis. 2010;161.
19.
Bosilkovski M, Krteva L, Dimzova M, Vidinic I, Sopova Z, Spasovska K. Humanbrucellosis in Macedonia -10 years of clinical experience in endemic region. Croat Med J. 2010;327–36.
20.
Soleimani G. Evaluation of clinical findings and treatment of childhood Brucellosis in Zahedan. Iran J PediatrSoc. 2010;53–7.
21.
Zamani A, Kooraki S, Mohazab R, Zamani N, Matloob R, Hayatbakhsh M, et al. Epidemiological and clinical features of Brucella arthritis in 24 children. Ann Saudi Med. 2011;270–3.
22.
Shen M. Diagnostic and therapeutic challenges of childhood brucellosis in a nonendemic country. Pediatrics. 2008;1178–83.
23.
Shahnaz A, Atoosa G, Abdollah K, Delara B, Nadere M. Brucellosis in children: A disease with multiple features. JPediatr Infect Dis. 2007;219–23.
24.
El-Koumi M, Afify M, Sh AZ. A prospective study of brucellosis in children: relative frequency of pancytopenia. Mediterr J Hematol Infect Dis. 2013;
25.
Almuneef M, Memish Z. Prevalence of Brucella antibodies after acute brucellosis. J Chemother. 2003;148–51.
26.
Mehanic S, Baljic R, Mulabdic V, Huric-Jusufi I, Pinjo F, Topalovic-Cetkovic J, et al. Osteoarticular manifestations of brucellosis. Med Arh. 2012;24–6.
27.
Ahmetagić S, Tihić N, Ahmetagić A, Čustović A, Smriko-Nuhanović A, Mehinović N, et al. Human Brucellosis in Tuzla Canton. Med Arh. 2012;309–14.
28.
Logan L, Jacobs N, Mcauley J, Weinstein R, Anderson E. A multicenter retrospective study of childhood brucellosis in Chicago, Illinois from 1986 to2008. Int J Infect Dis. 2011;812–7.
29.
Kambal AEY, Alrabeeah A, Abdullah A, Al-Jurayyan A, N. Osteoarticular brucellosis in children. Ann Rheum Dis. 1990;896–900.
30.
Grgić S, Nikolić J, Bradarić M, Skočibušić S. Epidemiološke i kliničke značajke bruceloze u djece. Infektol Glas. 2012;173–8.
31.
Lubani M, Dudin K, Sharda D, Ndhar D, Araj G, Hafez H, et al. A multicenter therapeutic study of 1100 children withbrucellosis. Pediatr Infect Dis J. 1989;75–8.
Kantonalna bolnica Zenica, Zenica, 4 Odjel za infektivne bolesti, Kantonalna bolnica Bihać, Bihać, 5 Klinika za infektivne bolesti, Klinička bolnica Mostar, Mostar, 6 Klinika za infektivne bolesti.
34.
Tuzli S, Luci B. Metode U ispitivanje je bilo uključeno 246 djece, u dobi do 18 godina, koja su bila hospitalizirana u klinikama i odjelima za infektivne bolesti u. (9):82.
35.
Zaključak S obzirom da je bruceloza endemska bolest u Bosni i Hercegovini važno je da liječnici u svom svakodnevnom radu imaju na umu ovu bolest i postave pravu dijagnozu, te odgovarajući tretman djeci sa simptomima u vidu produžene temperature, artralgijama, leukopenijom i pozitivnom epidemiološkom dijagnozom, posebno u ruralnim dijelovima zemlje.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
